Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFDA Approves First mRNA Vaccine Against RSV for Adults Aged ≥60 Years: Daily Dose.SubjectsUNITED States. Food &; Drug Administration; RESPIRATORY syncytial virus infection vaccines; HEALTH of adults; VACCINE effectiveness; VACCINE trialsPublicationPatient Care (Online), 2024, p2ISSN1939-1897Publication typeArticle